Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children.

This study has been completed.
Sponsor:
Collaborator:
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by:
MedImmune LLC
ClinicalTrials.gov Identifier:
NCT00192400
First received: September 13, 2005
Last updated: October 2, 2006
Last verified: October 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: November 2002
  Estimated Primary Completion Date: No date given
No publications provided by MedImmune LLC

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):